SNDL (SNDL) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
13 Nov, 2025Executive summary
Achieved record quarterly free cash flow of $16.7 million in Q3 2025 and first-ever positive cumulative free cash flow for the first nine months, totaling $7.7 million year-to-date.
Cannabis business delivered sustained double-digit revenue growth for the fifteenth consecutive quarter, with margin expansion in retail and reductions in SG&A expenses.
Reported operating loss of $11.1 million, mainly due to $11.9–$12 million in unfavorable non-cash items, including share-based compensation, inventory adjustments, and asset impairments.
Maintained a strong balance sheet with no debt and over $240 million in unrestricted cash as of September 30, 2025.
Continued progress on regulatory review for the acquisition of 32 1CM cannabis stores and investments in new store openings.
Financial highlights
Net revenue for Q3 2025 reached $244.2 million, up 3.1% year-over-year, driven by cannabis segments.
Gross profit was $64.2 million, a 1.9% increase year-over-year, despite $3.9 million in non-cash inventory adjustments.
Consolidated gross margin was 26.3%, down 0.3pp year-over-year due to inventory adjustments.
Adjusted operating loss was $9.5 million, a 42.7% improvement year-over-year.
Free cash flow for Q3 was $16.7 million, up 81% year-over-year.
Outlook and guidance
Expectation for cannabis operations gross margin to stabilize around 25% going forward.
Anticipate continued growth in international sales, supported by ramped-up production at Atholville facility.
Projected monthly production at Atholville to exceed 15,000 kg in 2026, with most output directed to international markets.
Cannabis retail revenue growth expected to remain in low single digits, with margins stabilizing.
Strategic priorities include driving sustainable growth, consistent free cash flow, and operating income growth.
Latest events from SNDL
- Record revenue, profitability, and cash flow driven by cannabis and retail growth.SNDL
Q4 202512 Mar 2026 - All resolutions passed, directors elected, and no shareholder questions were raised.SNDL
AGM 20242 Feb 2026 - Record gross margin and cannabis growth drive improved profitability and outlook.SNDL
Q2 20242 Feb 2026 - Record gross margin and cash flow highlight Q3 2024, with strong Cannabis segment growth.SNDL
Q3 202416 Jan 2026 - Record revenue, margin gains, and positive free cash flow driven by cannabis and efficiency.SNDL
Q4 202426 Dec 2025 - Record gross margin and thirteen quarters of cannabis growth drove improved Q1 2025 results.SNDL
Q1 202523 Dec 2025 - All resolutions passed, including director elections and compensation plans, with no shareholder questions.SNDL
AGM 202516 Nov 2025 - First-ever positive operating income and record margins, led by strong cannabis and liquor growth.SNDL
Q2 202516 Nov 2025 - Record gross margins and expanded retail footprint drive Q2 growth and profitability.SNDL
Corporate Presentation24 Sep 2025